Nonanticoagulant heparin prevents coronary endothelial dysfunction after brief ischemia-reperfusion injury in the dog

Circulation

Volumn 99, Issue 8, 1999, Pages 1062-1068

  Kouretas, Peter C ^a   Kim, Young D ^a   Cahill, Paul A ^a   Myers, Adam K ^a   To, Lam N ^a   Wang, Yi Ning ^a   Sitzmann, James V ^a   Hannan, Robert L ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Endothelium; Endothelium derived factors; Heparin; Ischemia; Reperfusion

Indexed keywords

CYCLIC GMP; HEPARIN; HEPARIN DERIVATIVE; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; DOG; HEART MUSCLE ISCHEMIA; HEPARINIZATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 0033515067     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.8.1062     Document Type: Article

References (34)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288: 373-376.
2. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biologic activity of endothelium-derived relaxing factor. Nature, 1987;327:524-526.
3. Ma XL, Weyrich AS, Lefer DJ, Lefer AM. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res. 1993;72:403-412.
4. VanBenthuysen KM, McMurtry IF, Horwitz LD. Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro. J Clin Invest. 1987;79:265-274.
5. Kim YD, Fomsgaard JS, Heim KF, Ramwell PW, Thomas G, Kagan E, Moore SP, Coughlin SS, Kuwahara M, Analouei A, Myers AK. Brief ischemia-reperfusion induces stunning of endothelium in canine coronary artery. Circulation. 1992;85:1473-1482.
6. Ma XL, Tsao PS, Lefer AM. Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. J Clin Invest. 1991;88:1237-1243.
7. Lefer AM, Siegfried MR, Ma XL. Protection of ischemia-reperfusion injury by sydnonimine NO donors via inhibition of neutrophil-endothelium interaction. J Cardiovasc Pharmacol. 1993;22(suppl 7):S27-S33.
8. Kim YD, Chen B, Beauregard J, Kouretas P, Thomas G, Farhat MY, Myers AK, Lees DE. 17β-Estradiol prevents dysfunction of canine coronary endothelium and myocardium and reperfusion arrhythmias after brief ischemia/reperfusion. Circulation. 1996;94:2901-2908.
9. Carr J. The antiinflammatory action of heparin: heparin as an antagonist to histamine, bradykinin, and PGE1. Thromb Res. 1979;16:507-516.
10. Oyanagui Y, Sato S. Heparin, a potent releasing agent of extracellular superoxide dismutase (EC-SOD C), suppresses ischaemic paw oedema in mice. Free Radic Res Commun. 1990;9:87-99.
11. Yokokawa K, Tahara H, Kohno M, Mandal AK, Yanagisawa M, Takeda T. Heparin regulates endothelin production through endothelium-derived nitric oxide in human endothelial cells. J Clin Invest. 1993;92: 2080-2085.
12. Minami M, Yokokawa K, Kohno M, Ikeda M, Horio T, Kano H, Hanehira T, Yasunari K, Takeda T. Promotion of nitric oxide formation by heparin in cultured aortic endothelial cells from spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 1995;22(suppl 1):S146-S147.
13. Hobson RW, Wright JG, Fox D, Kerr JC. Heparinization reduces endothelial permeability and hydrogen ion accumulation in a canine skeletal muscle ischemia-reperfusion model. J Vasc Surg. 1988;7:585-591.
14. Sternbergh WC III, Sobel M, Makhoul RG. Heparinoids with low anticoagulant potency attenuate postischemic endothelial cell dysfunction. J Vasc Surg. 1995;21:477-483.
15. Kouretas PC, Kim YD, Cahill PA, Myers AK, To LN, Wang YN, Wallace RB, Kron IL, Hannan RL. Heparin preserves nitric oxide activity in coronary endothelium during ischemia-reperfusion injury. Ann Thorac Surg. 1998;66:1210-1215.
16. Black SC, Gralinski MR, Friedrichs GS, Kilgore KS, Driscoll EM, Lucchesi BR. Cardioprotective effects of heparin or N-acetylheparin in an in vivo model of myocardial ischaemic and reperfusion injury. Cardiovasc Res. 1995;29:629-636.
17. Friedrichs GS, Kilgore KS, Manley PJ, Gralinski MR, Lucchesi BR. Effects of heparin and N-acetyl heparin on ischemia/reperfusion-induced alterations in myocardial function in the rabbit isolated heart. Circ Res. 1994;75:701-710.
18. Kouretas PC, Myers AK, Kim YD, Cahill PA, Myers JL, Wang YN, Sitzmann JV, Wallace RB, Hannan RL. Heparin and non-anticoagulant heparin preserve regional myocardial contractility after ischemia-reperfusion injury: role of nitric oxide. J Thorac Cardiovasc Surg. 1998; 115:440-449.
19. Kowallik P, Schulz, R, Guth BD, Schade A, Paffhausen W, Gross R, Heusch G. Measurement of regional myocardial blood flow with multiple colored microspheres. Circulation. 1991;83:974-982.
20. Romero JM, Lara C, Guerrero MG. Determination of intracellular nitrate. Biochem J. 1989;259:545-548.
21. Tsao PS, Aoki N, Lefer DJ, Johnson G, Lefer AM. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation. 1990;82:1402-1412.
22. Lefer DJ, Nakanishi K, Johnston WE, Vinten-Johansen J. Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion of dogs [see comments]. Circulation. 1993;88:2337-2350.
23. Weyrich AS, Ma XL, Lefer AM. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation. 1992;86:279-288.
24. Johnson G III, Tsao PS, Lefer AM. Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med. 1991;19:244-252.
25. Hiebert LM, Jaques LB. Heparin uptake on endothelium. Artery. 1976; 2:26-37.
26. Hiebert LM, Jaques LB. The observation of heparin on endothelium after injection. Thromb Res. 1976;8:195-204.
27. Yokokawa K, Kohno M, Tahara H, Mandal AK, Yasunari K, Murakawa K, Horio T, Ikeda M, Minami M, Takeda T. Effect of heparin on endothelin-1 production by cultured human endothelial cells. J Cardiovasc Pharmacol. 1993;22(suppl 8):S46-S48.
28. Piatti PM, Monti LD, Valsecchi G, Conti M, Nasser R, Guazzini B, Fochesato E, Phan CV, Pontiroli AE, Pozza G. Effects of low-dose heparin infusion on arterial endothelin-1 release in humans. Circulation. 1996;94:2703-2707.
29. Yokokawa K, Mankus R, Saklayen MG, Kohno M, Yasunari K, Minami M, Kano H, Horio T, Takeda T, Mandel AK. Increased nitric oxide production in patients with hypotension during hemodialysis [see comments]. Ann Intern Med. 1995;123:35-37.
30. Upchurch GR Jr, Welch GN, Freedman JE, Fabian AJ, Pigazzi A, Scribner AM, Alpert CS, Keaney JF Jr, Loscalzo J. High-dose heparin decreases nitric oxide production by cultured bovine endothelial cells. Circulation. 1997;95:2115-2121.
31. Kapur NK, Kouretas PC, Myers AK, Cahill PA, Kim YD, Wang YN, Redmond EM, Sitzmann JV, Hannan RL. Endothelial-dependent vasodilation of thoracic aorta by heparin and non-anticoagulant heparin. FASEB J. 1997;11:A79. Abstract.
32. Kouretas PC, Hannan RL, Kapur NS, Hendrickson R, Redmond EM, Myers AK, Kim YD, Cahill PA, Sitzmann JV. Non-anticoagulant heparin increases endothelial nitric oxide synthase activity: role of inhibitory guanine nucleotide proteins. J Mol Cell Cardiol. 1998;30:2669-2682.
33. Bezprozvanny IB, Ondrias K, Kaftan E, Stoyanovsky DA, Ehrlich BE. Activation of the calcium release channel (ryanodine receptor) by heparin and other polyanions is calcium dependent. Mol Biol Cell. 1993;4: 347-352.
34. Tsao PS, Ma XL, Lefer AM. Activated neutrophils aggravate endothelial dysfunction after reperfusion of the ischemic feline myocardium [see comments]. Am Heart J. 1992;123:1464-1471.